FDA Releases Draft Guidance for Herpes Simplex Virus Serological Assays

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document outlining the requirements for class II devices that test for herpes simplex virus types 1 and 2, in an effort to ensure compliance with special controls for these devices.